Skip to main content
. Author manuscript; available in PMC: 2014 Dec 3.
Published in final edited form as: Vaccine. 2014 Oct 16;32(50):6733–6745. doi: 10.1016/j.vaccine.2014.10.002

Figure 3. CD8+ T-cells from HSV-seropositive symptomatic and asymptomatic individuals recognize different gB epitopes.

Figure 3

CD8+ T-cells isolated from HLA-A*0201-matched symptomatic (n = 4) and asymptomatic patients (n = 16) were stimulated with autologous DC that were pulsed with 10 µg/ml of the indicated gB peptide for 5 days. The number of IFN-γ-producing CD8+ T-cells specific to each gB epitope was determined by IFN-γ-ELISpot assay in duplicate.